FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > I expect to see additional IND's for MS and Major Depression

<< Previous

Bullboard Posts

Next >>

Comment by JensLenson May 31, 2022 10:20am

60 Views

Post# 34719849

RE:RE:I expect to see additional IND's for MS and Major Depression

Mil_Man54 wrote: You have some insoder information pumper....car to share since you get compensated to pump this POS.

Nobody is compensated , I am compensated only one way , and if that stock price goes up if they can prove good results from the trials etc

another right move by FSD Pharma after IND is submitted and if they are approved then they can start trials for the infalmmation indiction.

I expect more IND for MS and depression

we got the phase 2 covered now for PEA

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects